K. Tokunaga

发表

Prevention of transmission of human T‐lymphotropic virus type 1 (HTLV‐1) through transfusion, by donor screening with antibody to the virus One‐year experience

S. Inaba, H. Sato, K. Okochi, 1989, Transfusion.

Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies

S. Yamasaki, S. Mineishi, K. Tokunaga, 2004, Bone Marrow Transplantation.

Preparation and storage of hematopoietic stem cell in Fukuoka Blood Center.

K. Tokunaga, H. Kiyokawa, Y. Maeda, 1992 .

An Ephidemiologic Survey of Hepatitis C Virus in Japan

S. Kashiwagi, J. Hayashi, A. Noguchi, 1993 .

HCV transmission after receiving anti-c100-negative blood units

S. Inaba, K. Okochi, K. Tokunaga, 1991, The Lancet.

Allolymphocytotoxic antibodies in sera from HTLV-I-associated myelopathy/tropical spastic paraparesis patients — putative anti-HLA antibodies

Y. Itoyama, K. Tokunaga, H. Kiyokawa, 1994, Journal of the Neurological Sciences.

KIDNEY TRANSPLANT REGRAFT RESULTS IMPROVED BY PEROPERATIVE BLOOD TRANSFUSIONS

K. Tokunaga, P. Terasaki, 1986, The Lancet.

Treatment of platelet‐alloimmunization with cyclosporin a in a patient with aplastic anemia

S. Inaba, K. Tokunaga, H. Kiyokawa, 1990, American journal of hematology.

A case of transfusion reaction associated with anti-IgA antibody.

K. Fukada, K. Tokunaga, H. Kiyokawa, 1990 .

Reliability of anti-HCV antibody screening systems. 1st Generation EIA, 2nd generation PHA, PA and a new EIA kit using synthetic paptide (AR142)- based on nested polymerase chain reaction.

K. Fukada, K. Tokunaga, H. Kiyokawa, 1992 .

Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.

K. Tokunaga, H. Kiyokawa, K. Tanaka, 1991, Cancer research.

Hepatitis C and Hepatitis B in the Etiology of Hepatocellular Carcinoma in the Japanese Population 1

K. Tokunaga, H. Kiyokawa, Keitaro Tanaka, 2006 .